TY  - JOUR
AU  - Sepúlveda Sánchez, Juan Manuel
AU  - Ramos González, Ana
AU  - Pérez Segura, Pedro
AU  - Hernández Laín, Aurelio
PY  - 2017
DO  - 10.1093/neuonc/nox105
SN  - 1522-8517
UR  - https://hdl.handle.net/20.500.14352/117069
T2  - Neuro-Oncology
AB  - Background. We conducted a multicenter, 2-stage, open-label, phase II trial to assess the efficacy and safety of dacomitinib in adult patients with recurrent glioblastoma (GB) and epidermal growth factor receptor gene (EGFR) amplification with or...
LA  - eng
M2  - 1522
PB  - Oxford Academic
KW  - EGFR
KW  - Dacomitinib
KW  - Glioblastoma
KW  - High-grade glioma
TI  - Phase II trial of dacomitinib, a pan‒human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification
TY  - journal article
VL  - 19
ER  -